Detalles de la búsqueda
1.
Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
Eur Heart J
; 45(3): 161-177, 2024 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638967
2.
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials.
Am Heart J
; 263: 73-84, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192697
3.
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
JAMA
; 327(18): 1771-1781, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368058
4.
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Am Heart J
; 238: 33-44, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951415
5.
Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillation.
Catheter Cardiovasc Interv
; 97(7): E1002-E1010, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022121
6.
Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI Registry.
JACC Cardiovasc Interv
; 17(1): 17-28, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199749
7.
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Atherosclerosis
; 392: 117504, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513436
8.
Robotic-assisted percutaneous coronary intervention: experience in Switzerland.
Front Cardiovasc Med
; 10: 1294930, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38116535
9.
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset.
Eur Heart J Acute Cardiovasc Care
; 12(6): 376-385, 2023 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996409
10.
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial.
EuroIntervention
; 19(4): e286-e296, 2023 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341586
11.
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
Thromb Haemost
; 2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595625
12.
Impact of Intracoronary Optical Coherence Tomography in Routine Clinical Practice: A Contemporary Cohort Study.
Cardiovasc Revasc Med
; 38: 96-103, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34340915
13.
Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.
Int J Cardiol
; 350: 1-8, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033577
14.
Impact of Echocardiographic Guidance on Safety and Efficacy of Left Atrial Appendage Closure: An Observational Study.
JACC Cardiovasc Interv
; 14(16): 1815-1826, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34412799
15.
In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study.
Eur Heart J Cardiovasc Imaging
; 22(7): 824-834, 2021 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31990323
Resultados
1 -
15
de 15
1
Próxima >
>>